Stay updated on Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.

Latest updates to the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page
- Check5 days agoChange DetectedA banner announces an NIH-wide terminology transition, and the site revision number changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe ClinicalTrials.gov error page footer now shows revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page now shows a 403 Forbidden error, preventing access to the study record and its related information. This indicates the content is temporarily unavailable to users.SummaryDifference18%

- Check40 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing Revision: v3.6.6. This indicates a software version update applied to the page rather than changes to the study details.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page’s revision label was updated from v3.6.5 to v3.6.6, indicating a newer page/template update. This likely reflects internal fixes or UI improvements without changing the study content.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page revision label updated from v3.6.4 to v3.6.5, indicating a new release of the site or page. This does not reflect changes to the study data or the content presented on the page.SummaryDifference0.1%

Stay in the know with updates to Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.